Literature DB >> 12270698

Pyramidal cell loss in motor cortices in Huntington's disease.

Virginia Macdonald1, Glenda Halliday.   

Abstract

Patterns of huntingtin protein aggregation and cortical neuronal loss suggest early involvement of corticostriatal pathways in Huntington's disease. However, theories of pathogenesis of chorea rely on the motor cortices being intact. The motor cortices have not previously been studied at a cellular level in Huntington's disease. We analyzed the neuronal number in the caudate, putamen, and three motor cortical areas in five cases of Huntington's disease and five controls. For each motor cortical region the total neuronal number, number of interneurons, and number of SMI32 immunopositive pyramidal neurons were quantified using previously published techniques and any relationship between cell loss and severity or duration of chorea was examined. The results showed a loss of long projecting SMI32 immunopositive pyramidal neurons in the primary motor cortex with associated morphological changes and suggest a loss of short projecting pyramidal neurons in the premotor cortex. Degeneration in the primary motor cortex correlated with subcortical degeneration. These findings indicate pyramidal cell involvement in Huntington's disease and implicate the degeneration of corticostriatal pathways in the production of chorea.

Entities:  

Mesh:

Year:  2002        PMID: 12270698     DOI: 10.1006/nbdi.2002.0528

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  25 in total

1.  Huntington's disease and mitochondrial alterations: emphasis on experimental models.

Authors:  Verónica Pérez-De la Cruz; Paul Carrillo-Mora; Abel Santamaría
Journal:  J Bioenerg Biomembr       Date:  2010-06       Impact factor: 2.945

2.  Decreased Lin7b expression in layer 5 pyramidal neurons may contribute to impaired corticostriatal connectivity in huntington disease.

Authors:  Birgit Zucker; Jibrin A Kama; Alexandre Kuhn; Doris Thu; Lianna R Orlando; Anthone W Dunah; Ozgun Gokce; David M Taylor; Johann Lambeck; Bernd Friedrich; Katrin S Lindenberg; Richard L M Faull; Cornelius Weiller; Anne B Young; Ruth Luthi-Carter
Journal:  J Neuropathol Exp Neurol       Date:  2010-09       Impact factor: 3.685

3.  Cortical Network Dynamics Is Altered in Mouse Models of Huntington's Disease.

Authors:  Elissa J Donzis; Ana María Estrada-Sánchez; Tim Indersmitten; Katerina Oikonomou; Conny H Tran; Catherine Wang; Shahrzad Latifi; Peyman Golshani; Carlos Cepeda; Michael S Levine
Journal:  Cereb Cortex       Date:  2020-04-14       Impact factor: 5.357

4.  Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.

Authors:  H Diana Rosas; David H Salat; Stephanie Y Lee; Alexandra K Zaleta; Vasanth Pappu; Bruce Fischl; Doug Greve; Nathanael Hevelone; Steven M Hersch
Journal:  Brain       Date:  2008-03-12       Impact factor: 13.501

Review 5.  Cell therapy in Huntington's disease.

Authors:  Stephen B Dunnett; Anne E Rosser
Journal:  NeuroRx       Date:  2004-10

6.  Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease.

Authors:  Yi Hong; Lauren J O'Donnell; Peter Savadjiev; Fan Zhang; Demian Wassermann; Ofer Pasternak; Hans Johnson; Jane Paulsen; Jean-Paul Vonsattel; Nikos Makris; Carl F Westin; Yogesh Rathi
Journal:  Hum Brain Mapp       Date:  2018-05-24       Impact factor: 5.038

7.  The structural correlates of functional deficits in early huntington's disease.

Authors:  Christine Delmaire; Eve M Dumas; Michael A Sharman; Simon J A van den Bogaard; Romain Valabregue; Céline Jauffret; Damian Justo; Ralf Reilmann; Julie C Stout; David Craufurd; Sarah J Tabrizi; Raymund A C Roos; Alexandra Durr; Stéphane Lehéricy
Journal:  Hum Brain Mapp       Date:  2012-03-22       Impact factor: 5.038

Review 8.  Role of p53 in neurodegenerative diseases.

Authors:  J Robert Chang; Mohammad Ghafouri; Ruma Mukerjee; Asen Bagashev; Tinatin Chabrashvili; Bassel E Sawaya
Journal:  Neurodegener Dis       Date:  2011-10-28       Impact factor: 2.977

9.  Expression analysis of novel striatal-enriched genes in Huntington disease.

Authors:  Gelareh Mazarei; Scott J Neal; Kristina Becanovic; Ruth Luthi-Carter; Elizabeth M Simpson; Blair R Leavitt
Journal:  Hum Mol Genet       Date:  2009-11-23       Impact factor: 6.150

10.  Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice.

Authors:  Y P Deng; T Wong; C Bricker-Anthony; B Deng; A Reiner
Journal:  Neurobiol Dis       Date:  2013-08-19       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.